|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.120 EUR | +2.28% |
|
+5.42% | +10.81% |
| 02-03 | Global markets live: SpaceX, Tesla, Boeing, PayPal, AstraZeneca… |  |
| 02-03 | Valneva, Instituto Butantan Start Pilot Program for Chikungunya Vaccine in Brazil | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 4.432 | 5.09 | 5.045 |
| Spread/Res. | -7.04% | -19.06% | -18.33% |
| Spread/Supp. | +10.81% | +18.46% | +19.35% |
| Support | 3.718 | 3.478 | 3.452 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- VLA Stock
- Charts Valneva
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition